Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease

NCT02133924 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Acute Graft Versus Host Disease

Interventions

DRUG: natalizumab
DRUG: steroids

Sponsor

John Levine

Collaborators

[object Object]